Rank | Gene Set | Z-score |
---|---|---|
1 | hemidesmosome assembly (GO:0031581) | 4.29112554 |
2 | detection of molecule of bacterial origin (GO:0032490) | 4.07072848 |
3 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.02238560 |
4 | protein carboxylation (GO:0018214) | 4.02238560 |
5 | L-phenylalanine catabolic process (GO:0006559) | 3.88742568 |
6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.88742568 |
7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.85293815 |
8 | desmosome organization (GO:0002934) | 3.76948240 |
9 | phospholipid efflux (GO:0033700) | 3.76770781 |
10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.73301964 |
11 | L-phenylalanine metabolic process (GO:0006558) | 3.73301964 |
12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.72694843 |
13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.72694843 |
14 | modulation by symbiont of host immune response (GO:0052553) | 3.72694843 |
15 | positive regulation by symbiont of host defense response (GO:0052509) | 3.72694843 |
16 | modulation by symbiont of host defense response (GO:0052031) | 3.72694843 |
17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.72694843 |
18 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.62464207 |
19 | regulation of protein activation cascade (GO:2000257) | 3.58866034 |
20 | aromatic amino acid family catabolic process (GO:0009074) | 3.58763981 |
21 | detection of external biotic stimulus (GO:0098581) | 3.57594651 |
22 | high-density lipoprotein particle remodeling (GO:0034375) | 3.57376664 |
23 | complement activation, alternative pathway (GO:0006957) | 3.53902502 |
24 | regulation of complement activation (GO:0030449) | 3.45693827 |
25 | tryptophan catabolic process (GO:0006569) | 3.43476668 |
26 | indole-containing compound catabolic process (GO:0042436) | 3.43476668 |
27 | indolalkylamine catabolic process (GO:0046218) | 3.43476668 |
28 | macrophage activation involved in immune response (GO:0002281) | 3.39577890 |
29 | response to peptidoglycan (GO:0032494) | 3.37484929 |
30 | fibrinolysis (GO:0042730) | 3.35559497 |
31 | reverse cholesterol transport (GO:0043691) | 3.35082314 |
32 | regulation of cholesterol esterification (GO:0010872) | 3.34396027 |
33 | sulfur amino acid catabolic process (GO:0000098) | 3.33800776 |
34 | tryptophan metabolic process (GO:0006568) | 3.30860435 |
35 | kynurenine metabolic process (GO:0070189) | 3.28901744 |
36 | urea cycle (GO:0000050) | 3.26680426 |
37 | urea metabolic process (GO:0019627) | 3.26680426 |
38 | negative regulation of fibrinolysis (GO:0051918) | 3.24150704 |
39 | glyoxylate metabolic process (GO:0046487) | 3.23705918 |
40 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.18401376 |
41 | neutrophil activation involved in immune response (GO:0002283) | 3.17567791 |
42 | amino-acid betaine metabolic process (GO:0006577) | 3.15957929 |
43 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.15390754 |
44 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.14017455 |
45 | regulation of fibrinolysis (GO:0051917) | 3.11659189 |
46 | bile acid biosynthetic process (GO:0006699) | 3.11514858 |
47 | cellular glucuronidation (GO:0052695) | 3.11431364 |
48 | regulation of triglyceride catabolic process (GO:0010896) | 3.10071378 |
49 | detection of biotic stimulus (GO:0009595) | 3.09697213 |
50 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.09283635 |
51 | phospholipid homeostasis (GO:0055091) | 3.01235903 |
52 | homocysteine metabolic process (GO:0050667) | 3.00910742 |
53 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.98055725 |
54 | plasma lipoprotein particle remodeling (GO:0034369) | 2.96402597 |
55 | protein-lipid complex remodeling (GO:0034368) | 2.96402597 |
56 | macromolecular complex remodeling (GO:0034367) | 2.96402597 |
57 | bile acid and bile salt transport (GO:0015721) | 2.96302659 |
58 | cysteine metabolic process (GO:0006534) | 2.95871978 |
59 | nitrogen cycle metabolic process (GO:0071941) | 2.95825832 |
60 | glucuronate metabolic process (GO:0019585) | 2.95018986 |
61 | uronic acid metabolic process (GO:0006063) | 2.95018986 |
62 | plasma lipoprotein particle clearance (GO:0034381) | 2.92938013 |
63 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.90430182 |
64 | negative regulation of cell killing (GO:0031342) | 2.89125122 |
65 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.89125122 |
66 | glycosphingolipid catabolic process (GO:0046479) | 2.89087003 |
67 | cholesterol efflux (GO:0033344) | 2.88433701 |
68 | alpha-linolenic acid metabolic process (GO:0036109) | 2.87573203 |
69 | regulation of cholesterol homeostasis (GO:2000188) | 2.86554396 |
70 | negative regulation of protein activation cascade (GO:2000258) | 2.86184022 |
71 | negative regulation of cholesterol transport (GO:0032375) | 2.83016748 |
72 | negative regulation of sterol transport (GO:0032372) | 2.83016748 |
73 | negative regulation of complement activation (GO:0045916) | 2.82101624 |
74 | carnitine metabolic process (GO:0009437) | 2.82062178 |
75 | cellular extravasation (GO:0045123) | 2.81254364 |
76 | lipoprotein metabolic process (GO:0042157) | 2.80976949 |
77 | protein localization to endosome (GO:0036010) | 2.79908639 |
78 | lysine metabolic process (GO:0006553) | 2.79770451 |
79 | lysine catabolic process (GO:0006554) | 2.79770451 |
80 | positive regulation of extracellular matrix organization (GO:1903055) | 2.78819516 |
81 | peptide catabolic process (GO:0043171) | 2.78672294 |
82 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.77292329 |
83 | negative regulation of interleukin-12 production (GO:0032695) | 2.73826659 |
84 | regulation of apoptotic cell clearance (GO:2000425) | 2.73652816 |
85 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.72350435 |
86 | angiotensin maturation (GO:0002003) | 2.70970385 |
87 | pinocytosis (GO:0006907) | 2.70883867 |
88 | acute-phase response (GO:0006953) | 2.70712799 |
89 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.70704433 |
90 | ethanol oxidation (GO:0006069) | 2.70655580 |
91 | tyrosine metabolic process (GO:0006570) | 2.70353269 |
92 | bile acid metabolic process (GO:0008206) | 2.70008896 |
93 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.69549885 |
94 | alkaloid metabolic process (GO:0009820) | 2.69545070 |
95 | benzene-containing compound metabolic process (GO:0042537) | 2.66592062 |
96 | drug catabolic process (GO:0042737) | 2.66591654 |
97 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.66333360 |
98 | skin morphogenesis (GO:0043589) | 2.63353206 |
99 | barbed-end actin filament capping (GO:0051016) | 2.63256959 |
100 | glycolipid catabolic process (GO:0019377) | 2.63109484 |
101 | acylglycerol homeostasis (GO:0055090) | 2.62712676 |
102 | triglyceride homeostasis (GO:0070328) | 2.62712676 |
103 | ethanol metabolic process (GO:0006067) | 2.59914011 |
104 | negative regulation of lipase activity (GO:0060192) | 2.59808985 |
105 | opsonization (GO:0008228) | 2.59224570 |
106 | negative regulation of humoral immune response (GO:0002921) | 2.58752234 |
107 | complement activation (GO:0006956) | 2.58348654 |
108 | hypotonic response (GO:0006971) | 2.57621275 |
109 | positive regulation of lipid catabolic process (GO:0050996) | 2.57281288 |
110 | aromatic amino acid family metabolic process (GO:0009072) | 2.56839028 |
111 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.56673386 |
112 | low-density lipoprotein particle remodeling (GO:0034374) | 2.56531041 |
113 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.54403481 |
114 | primary alcohol catabolic process (GO:0034310) | 2.53889723 |
115 | cholesterol homeostasis (GO:0042632) | 2.53862290 |
116 | positive regulation of leukocyte degranulation (GO:0043302) | 2.53475850 |
117 | flavonoid metabolic process (GO:0009812) | 2.53382994 |
118 | sterol homeostasis (GO:0055092) | 2.52211481 |
119 | hormone catabolic process (GO:0042447) | 2.52156561 |
120 | complement activation, classical pathway (GO:0006958) | 2.51709271 |
121 | plasma lipoprotein particle assembly (GO:0034377) | 2.51355845 |
122 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.51046906 |
123 | negative regulation of blood coagulation (GO:0030195) | 2.50993333 |
124 | negative regulation of hemostasis (GO:1900047) | 2.50993333 |
125 | oligosaccharide catabolic process (GO:0009313) | 2.50392467 |
126 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.49667555 |
127 | intestinal cholesterol absorption (GO:0030299) | 2.48891198 |
128 | protein activation cascade (GO:0072376) | 2.48770627 |
129 | macrophage activation (GO:0042116) | 2.47896066 |
130 | xenobiotic catabolic process (GO:0042178) | 2.47527445 |
131 | regulation of leukocyte degranulation (GO:0043300) | 2.47479703 |
132 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.47431504 |
133 | cellular modified amino acid catabolic process (GO:0042219) | 2.46437207 |
134 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.45651721 |
135 | immunoglobulin mediated immune response (GO:0016064) | 2.45292817 |
136 | surfactant homeostasis (GO:0043129) | 2.45058582 |
137 | embryonic process involved in female pregnancy (GO:0060136) | 2.44724478 |
138 | cell adhesion mediated by integrin (GO:0033627) | 2.44652145 |
139 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.44645406 |
140 | response to host (GO:0075136) | 2.44645406 |
141 | response to host defenses (GO:0052200) | 2.44645406 |
142 | negative regulation of coagulation (GO:0050819) | 2.44645353 |
143 | epoxygenase P450 pathway (GO:0019373) | 2.44014748 |
144 | apoptotic cell clearance (GO:0043277) | 2.43889553 |
145 | indolalkylamine metabolic process (GO:0006586) | 2.43113780 |
146 | T-helper 1 type immune response (GO:0042088) | 2.42448287 |
147 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.41884124 |
148 | protein-lipid complex assembly (GO:0065005) | 2.41770348 |
149 | response to laminar fluid shear stress (GO:0034616) | 2.41755058 |
150 | detection of bacterium (GO:0016045) | 2.41031482 |
151 | negative regulation of fatty acid transport (GO:2000192) | 2.40754707 |
152 | drug transmembrane transport (GO:0006855) | 2.40614747 |
153 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.40534191 |
154 | positive regulation of blood coagulation (GO:0030194) | 2.39767483 |
155 | positive regulation of hemostasis (GO:1900048) | 2.39767483 |
156 | regulation of macrophage chemotaxis (GO:0010758) | 2.39754625 |
157 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.39236550 |
158 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.38880825 |
159 | detection of other organism (GO:0098543) | 2.38373778 |
160 | regulation of bile acid biosynthetic process (GO:0070857) | 2.37997779 |
161 | urate metabolic process (GO:0046415) | 2.37372180 |
162 | regulation of extracellular matrix disassembly (GO:0010715) | 2.37020397 |
163 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.35057659 |
164 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.33740256 |
165 | regulation of mast cell degranulation (GO:0043304) | 2.33271419 |
166 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.33112524 |
167 | response to host immune response (GO:0052572) | 2.33112524 |
168 | positive regulation of receptor recycling (GO:0001921) | 2.33048187 |
169 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.28819287 |
170 | positive regulation of coagulation (GO:0050820) | 2.28102193 |
171 | basement membrane organization (GO:0071711) | 2.28051952 |
172 | iron ion import (GO:0097286) | 2.27583178 |
173 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.24954742 |
174 | low-density lipoprotein particle clearance (GO:0034383) | 2.21719731 |
175 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.21076796 |
176 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.21023062 |
177 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.20339319 |
178 | microglial cell activation (GO:0001774) | 2.19953023 |
179 | regulation of tolerance induction (GO:0002643) | 2.19770035 |
180 | regulation of T cell tolerance induction (GO:0002664) | 2.19007209 |
181 | regulation of macrophage cytokine production (GO:0010935) | 2.18381437 |
182 | positive regulation of phagocytosis (GO:0050766) | 2.16772090 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.97718013 |
2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.72622626 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.18779142 |
4 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.77209814 |
5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.74356748 |
6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.60908779 |
7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.24767052 |
8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.20364584 |
9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.97766754 |
10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.59509999 |
11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.55321384 |
12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.32740049 |
13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.32704714 |
14 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.26885193 |
15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.26196476 |
16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.10472471 |
17 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.07855726 |
18 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.06487676 |
19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.02384878 |
20 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.90961829 |
21 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.86327003 |
22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.81711522 |
23 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.81199158 |
24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.81015392 |
25 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.77147611 |
26 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.71237897 |
27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.69288969 |
28 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.62788934 |
29 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.62422783 |
30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.58852009 |
31 | CJUN_26792858_Chip-Seq_BT549_Human | 1.57978097 |
32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.53938083 |
33 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.53327631 |
34 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.52910955 |
35 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.48656236 |
36 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.48654699 |
37 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.48654699 |
38 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.48578052 |
39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.48401870 |
40 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.47000046 |
41 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.45047816 |
42 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.44125610 |
43 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.42256202 |
44 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.41631879 |
45 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.41480488 |
46 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.39368119 |
47 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.37751033 |
48 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.37640645 |
49 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.37640645 |
50 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.35577773 |
51 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.34537452 |
52 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.33632924 |
53 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32473454 |
54 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.31764002 |
55 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31257967 |
56 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.27151246 |
57 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.26910337 |
58 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.26529880 |
59 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.26431232 |
60 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.26170526 |
61 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.24485565 |
62 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.24370926 |
63 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.21216737 |
64 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21022996 |
65 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20620881 |
66 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.20046593 |
67 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.19470221 |
68 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18976498 |
69 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.18788541 |
70 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.18335385 |
71 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.16759367 |
72 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.12550588 |
73 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.11990260 |
74 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.10280337 |
75 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.09597824 |
76 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.08866752 |
77 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.08432937 |
78 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.08398912 |
79 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.07980220 |
80 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07386595 |
81 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.06435754 |
82 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05180774 |
83 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.03944667 |
84 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.02395035 |
85 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.01961817 |
86 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.01881975 |
87 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.01642342 |
88 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01086306 |
89 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00251819 |
90 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.99648612 |
91 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.99573975 |
92 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99116555 |
93 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98071112 |
94 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.97872381 |
95 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95441592 |
96 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.95265768 |
97 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95074548 |
98 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.95037160 |
99 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.94307145 |
100 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.94107185 |
101 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93505420 |
102 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.92431408 |
103 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92322818 |
104 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.90395137 |
105 | MAF_26560356_Chip-Seq_TH1_Human | 0.90214386 |
106 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.86687600 |
107 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85276100 |
108 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.85121608 |
109 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.85121608 |
110 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84466986 |
111 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83599852 |
112 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.83218333 |
113 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.81545083 |
114 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81459697 |
115 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.80695022 |
116 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.79980486 |
117 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.79740630 |
118 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.79123136 |
119 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.79099595 |
120 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.77914516 |
121 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.77534342 |
122 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76274440 |
123 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.75622910 |
124 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.74648661 |
125 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.73885015 |
126 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.73694929 |
127 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.73315387 |
128 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.72312223 |
129 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.71628549 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 4.29288425 |
2 | MP0002139_abnormal_hepatobiliary_system | 4.13868312 |
3 | MP0002254_reproductive_system_inflammat | 3.64510570 |
4 | MP0005085_abnormal_gallbladder_physiolo | 3.41926543 |
5 | MP0005365_abnormal_bile_salt | 3.01690618 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 2.89897024 |
7 | MP0003191_abnormal_cellular_cholesterol | 2.72661786 |
8 | MP0003705_abnormal_hypodermis_morpholog | 2.60641151 |
9 | MP0005275_abnormal_skin_tensile | 2.59558943 |
10 | MP0003252_abnormal_bile_duct | 2.58045067 |
11 | MP0009840_abnormal_foam_cell | 2.54542522 |
12 | MP0008438_abnormal_cutaneous_collagen | 2.30279995 |
13 | MP0002796_impaired_skin_barrier | 2.27399588 |
14 | MP0010234_abnormal_vibrissa_follicle | 2.26289176 |
15 | MP0002138_abnormal_hepatobiliary_system | 2.26288080 |
16 | MP0003195_calcinosis | 2.08415050 |
17 | MP0001666_abnormal_nutrient_absorption | 1.88978945 |
18 | MP0002060_abnormal_skin_morphology | 1.88297268 |
19 | MP0010329_abnormal_lipoprotein_level | 1.82194052 |
20 | MP0003724_increased_susceptibility_to | 1.78990264 |
21 | MP0003453_abnormal_keratinocyte_physiol | 1.76830643 |
22 | MP0003300_gastrointestinal_ulcer | 1.74665500 |
23 | MP0003172_abnormal_lysosome_physiology | 1.72377601 |
24 | MP0003183_abnormal_peptide_metabolism | 1.66864399 |
25 | MP0004019_abnormal_vitamin_homeostasis | 1.64771623 |
26 | MP0003566_abnormal_cell_adhesion | 1.64756915 |
27 | MP0008260_abnormal_autophagy | 1.64329775 |
28 | MP0005083_abnormal_biliary_tract | 1.59063665 |
29 | MP0003436_decreased_susceptibility_to | 1.58042380 |
30 | MP0000858_altered_metastatic_potential | 1.54524011 |
31 | MP0003806_abnormal_nucleotide_metabolis | 1.52754574 |
32 | MP0003091_abnormal_cell_migration | 1.52413797 |
33 | MP0009764_decreased_sensitivity_to | 1.51413508 |
34 | MP0005409_darkened_coat_color | 1.43454922 |
35 | MP0005332_abnormal_amino_acid | 1.42576827 |
36 | MP0004947_skin_inflammation | 1.41350132 |
37 | MP0005023_abnormal_wound_healing | 1.40763187 |
38 | MP0010368_abnormal_lymphatic_system | 1.36060837 |
39 | MP0000604_amyloidosis | 1.34233845 |
40 | MP0004272_abnormal_basement_membrane | 1.34033877 |
41 | MP0001346_abnormal_lacrimal_gland | 1.32886447 |
42 | MP0001216_abnormal_epidermal_layer | 1.32647815 |
43 | MP0004782_abnormal_surfactant_physiolog | 1.30532209 |
44 | MP0010678_abnormal_skin_adnexa | 1.29522197 |
45 | MP0000609_abnormal_liver_physiology | 1.29322521 |
46 | MP0003941_abnormal_skin_development | 1.27756997 |
47 | MP0000383_abnormal_hair_follicle | 1.27747581 |
48 | MP0005000_abnormal_immune_tolerance | 1.26911770 |
49 | MP0004883_abnormal_blood_vessel | 1.26316304 |
50 | MP0000579_abnormal_nail_morphology | 1.23755415 |
51 | MP0005257_abnormal_intraocular_pressure | 1.23432955 |
52 | MP0003448_altered_tumor_morphology | 1.21052656 |
53 | MP0001835_abnormal_antigen_presentation | 1.19648769 |
54 | MP0002148_abnormal_hypersensitivity_rea | 1.18299554 |
55 | MP0009643_abnormal_urine_homeostasis | 1.18225853 |
56 | MP0009384_cardiac_valve_regurgitation | 1.17736920 |
57 | MP0001533_abnormal_skeleton_physiology | 1.15486718 |
58 | * MP0002452_abnormal_antigen_presenting | 1.13387290 |
59 | MP0005503_abnormal_tendon_morphology | 1.13289448 |
60 | MP0002098_abnormal_vibrissa_morphology | 1.12072670 |
61 | MP0009785_altered_susceptibility_to | 1.11703881 |
62 | MP0004264_abnormal_extraembryonic_tissu | 1.11507808 |
63 | MP0005319_abnormal_enzyme/_coenzyme | 1.10557132 |
64 | MP0005501_abnormal_skin_physiology | 1.09648699 |
65 | MP0002118_abnormal_lipid_homeostasis | 1.09129595 |
66 | MP0000767_abnormal_smooth_muscle | 1.08603992 |
67 | MP0003279_aneurysm | 1.08321792 |
68 | * MP0002723_abnormal_immune_serum | 1.06181257 |
69 | MP0010352_gastrointestinal_tract_polyps | 1.06166562 |
70 | MP0002896_abnormal_bone_mineralization | 1.05105758 |
71 | MP0002405_respiratory_system_inflammati | 1.02749297 |
72 | MP0003690_abnormal_glial_cell | 1.02487569 |
73 | MP0002295_abnormal_pulmonary_circulatio | 1.01780828 |
74 | * MP0001800_abnormal_humoral_immune | 1.01096241 |
75 | MP0000465_gastrointestinal_hemorrhage | 1.00803135 |
76 | MP0002132_abnormal_respiratory_system | 1.00688937 |
77 | MP0001853_heart_inflammation | 1.00218250 |
78 | MP0004858_abnormal_nervous_system | 0.99789198 |
79 | MP0002166_altered_tumor_susceptibility | 0.99442541 |
80 | MP0005076_abnormal_cell_differentiation | 0.99179478 |
81 | MP0006082_CNS_inflammation | 0.97177195 |
82 | MP0000249_abnormal_blood_vessel | 0.96485723 |
83 | MP0005390_skeleton_phenotype | 0.96373790 |
84 | MP0009053_abnormal_anal_canal | 0.95669341 |
85 | MP0010155_abnormal_intestine_physiology | 0.94185238 |
86 | * MP0008469_abnormal_protein_level | 0.93776107 |
87 | MP0003868_abnormal_feces_composition | 0.93422211 |
88 | MP0000467_abnormal_esophagus_morphology | 0.93144626 |
89 | MP0002419_abnormal_innate_immunity | 0.92892197 |
90 | * MP0001819_abnormal_immune_cell | 0.92837388 |
91 | MP0001915_intracranial_hemorrhage | 0.92571039 |
92 | MP0008004_abnormal_stomach_pH | 0.92205593 |
93 | * MP0002420_abnormal_adaptive_immunity | 0.91919144 |
94 | MP0001958_emphysema | 0.91683458 |
95 | MP0001243_abnormal_dermal_layer | 0.90994604 |
96 | MP0003075_altered_response_to | 0.90363397 |
97 | MP0001849_ear_inflammation | 0.89653828 |
98 | MP0000538_abnormal_urinary_bladder | 0.89637040 |
99 | MP0000343_altered_response_to | 0.89219019 |
100 | MP0005451_abnormal_body_composition | 0.88966712 |
101 | MP0010771_integument_phenotype | 0.88554768 |
102 | MP0005164_abnormal_response_to | 0.88021223 |
103 | MP0002136_abnormal_kidney_physiology | 0.87324915 |
104 | MP0004510_myositis | 0.86896333 |
105 | MP0001879_abnormal_lymphatic_vessel | 0.85412707 |
106 | MP0000685_abnormal_immune_system | 0.85197343 |
107 | MP0009763_increased_sensitivity_to | 0.84852195 |
108 | MP0003329_amyloid_beta_deposits | 0.84436990 |
109 | MP0003303_peritoneal_inflammation | 0.83977167 |
110 | MP0004381_abnormal_hair_follicle | 0.83804042 |
111 | MP0003866_abnormal_defecation | 0.82694860 |
112 | MP0001845_abnormal_inflammatory_respons | 0.81821684 |
113 | MP0001851_eye_inflammation | 0.81762546 |
114 | MP0002933_joint_inflammation | 0.81718532 |
115 | MP0003186_abnormal_redox_activity | 0.80840257 |
116 | MP0000377_abnormal_hair_follicle | 0.80636474 |
117 | MP0006054_spinal_hemorrhage | 0.80583423 |
118 | MP0001756_abnormal_urination | 0.80485225 |
119 | MP0005387_immune_system_phenotype | 0.80188424 |
120 | MP0001790_abnormal_immune_system | 0.80188424 |
121 | MP0003828_pulmonary_edema | 0.79928964 |
122 | * MP0005025_abnormal_response_to | 0.79859024 |
123 | MP0003795_abnormal_bone_structure | 0.79783858 |
124 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.78916230 |
125 | MP0002971_abnormal_brown_adipose | 0.77314033 |
126 | MP0005165_increased_susceptibility_to | 0.77027724 |
127 | MP0005058_abnormal_lysosome_morphology | 0.76883262 |
128 | MP0002877_abnormal_melanocyte_morpholog | 0.75832771 |
129 | MP0001191_abnormal_skin_condition | 0.75814682 |
130 | MP0002998_abnormal_bone_remodeling | 0.75187664 |
131 | MP0005166_decreased_susceptibility_to | 0.74183286 |
132 | MP0005464_abnormal_platelet_physiology | 0.74045772 |
133 | MP0005167_abnormal_blood-brain_barrier | 0.73982966 |
134 | MP0001542_abnormal_bone_strength | 0.72311322 |
135 | MP0000427_abnormal_hair_cycle | 0.71691322 |
136 | MP0009931_abnormal_skin_appearance | 0.71597637 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Right ventricular cardiomyopathy (HP:0011663) | 4.48956861 |
2 | Deep venous thrombosis (HP:0002625) | 4.36727798 |
3 | Xanthomatosis (HP:0000991) | 4.23170981 |
4 | Intrahepatic cholestasis (HP:0001406) | 4.07035770 |
5 | Complement deficiency (HP:0004431) | 4.06756134 |
6 | Systemic lupus erythematosus (HP:0002725) | 3.96053459 |
7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.72193288 |
8 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.54700954 |
9 | Abnormality of complement system (HP:0005339) | 3.51159171 |
10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.50702774 |
11 | Prolonged partial thromboplastin time (HP:0003645) | 3.42979879 |
12 | Abnormality of glycolipid metabolism (HP:0010969) | 3.41402804 |
13 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.41402804 |
14 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.41402804 |
15 | Abnormality of macrophages (HP:0004311) | 3.40604551 |
16 | Atrophic scars (HP:0001075) | 3.35021377 |
17 | Thick nail (HP:0001805) | 3.30944996 |
18 | Abnormality of the common coagulation pathway (HP:0010990) | 3.23636306 |
19 | Plantar hyperkeratosis (HP:0007556) | 3.23554462 |
20 | Myocardial infarction (HP:0001658) | 3.22377049 |
21 | Onycholysis (HP:0001806) | 3.15344209 |
22 | Glomerulonephritis (HP:0000099) | 3.14319062 |
23 | Joint hemorrhage (HP:0005261) | 3.12761919 |
24 | Recurrent abscess formation (HP:0002722) | 3.09609079 |
25 | Hypobetalipoproteinemia (HP:0003563) | 3.01219566 |
26 | Hypoalphalipoproteinemia (HP:0003233) | 3.00536558 |
27 | Eczematoid dermatitis (HP:0000976) | 2.99151209 |
28 | Recurrent bacterial skin infections (HP:0005406) | 2.98264125 |
29 | Nephritis (HP:0000123) | 2.94566000 |
30 | Arterial tortuosity (HP:0005116) | 2.93882988 |
31 | Milia (HP:0001056) | 2.92864831 |
32 | Hyperlipoproteinemia (HP:0010980) | 2.87643604 |
33 | Myositis (HP:0100614) | 2.86077427 |
34 | Abnormality of proline metabolism (HP:0010907) | 2.85916009 |
35 | Hydroxyprolinuria (HP:0003080) | 2.85916009 |
36 | Hypolipoproteinemia (HP:0010981) | 2.85605519 |
37 | Cardiovascular calcification (HP:0011915) | 2.83899027 |
38 | Alopecia of scalp (HP:0002293) | 2.83848013 |
39 | Vascular tortuosity (HP:0004948) | 2.81335355 |
40 | Hypoglycemic coma (HP:0001325) | 2.81036547 |
41 | Peritonitis (HP:0002586) | 2.80314767 |
42 | Dysostosis multiplex (HP:0000943) | 2.79728633 |
43 | Vertebral compression fractures (HP:0002953) | 2.79367668 |
44 | Vascular calcification (HP:0004934) | 2.76452134 |
45 | Fragile nails (HP:0001808) | 2.74003572 |
46 | Epidermoid cyst (HP:0200040) | 2.72697355 |
47 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.71397785 |
48 | Mucopolysacchariduria (HP:0008155) | 2.71397785 |
49 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.65708415 |
50 | Esophageal varix (HP:0002040) | 2.64790960 |
51 | Osteolytic defects of the hand bones (HP:0009699) | 2.63893257 |
52 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.63893257 |
53 | Amyloidosis (HP:0011034) | 2.60706624 |
54 | Gingivitis (HP:0000230) | 2.58925796 |
55 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.57108664 |
56 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.57108664 |
57 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.57108664 |
58 | Abnormality of the intrinsic pathway (HP:0010989) | 2.56263298 |
59 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.53460007 |
60 | Fat malabsorption (HP:0002630) | 2.51089258 |
61 | Premature rupture of membranes (HP:0001788) | 2.49591062 |
62 | Spontaneous hematomas (HP:0007420) | 2.48899741 |
63 | Palmoplantar hyperkeratosis (HP:0000972) | 2.44233634 |
64 | Gastrointestinal infarctions (HP:0005244) | 2.42806439 |
65 | Hyperammonemia (HP:0001987) | 2.40535482 |
66 | Optic neuritis (HP:0100653) | 2.40229476 |
67 | Retrobulbar optic neuritis (HP:0100654) | 2.40229476 |
68 | Flat acetabular roof (HP:0003180) | 2.35918277 |
69 | Conjugated hyperbilirubinemia (HP:0002908) | 2.34163803 |
70 | Mitral stenosis (HP:0001718) | 2.29438408 |
71 | Hypercholesterolemia (HP:0003124) | 2.28923109 |
72 | Hepatocellular carcinoma (HP:0001402) | 2.28008178 |
73 | Loss of speech (HP:0002371) | 2.25515128 |
74 | Hematochezia (HP:0002573) | 2.23490171 |
75 | Purpura (HP:0000979) | 2.22858572 |
76 | Palmar hyperkeratosis (HP:0010765) | 2.21866882 |
77 | Abnormality of purine metabolism (HP:0004352) | 2.18007030 |
78 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.17694042 |
79 | Ketosis (HP:0001946) | 2.17420130 |
80 | Spondylolisthesis (HP:0003302) | 2.16694642 |
81 | Cervical subluxation (HP:0003308) | 2.13358938 |
82 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.13051400 |
83 | Dilatation of the ascending aorta (HP:0005111) | 2.12894062 |
84 | Increased cerebral lipofuscin (HP:0011813) | 2.09624559 |
85 | Abnormality of the peritoneum (HP:0002585) | 2.07769385 |
86 | Interstitial pulmonary disease (HP:0006530) | 2.06826039 |
87 | Aneurysm (HP:0002617) | 2.05564508 |
88 | Thin bony cortex (HP:0002753) | 2.04557260 |
89 | Axonal loss (HP:0003447) | 2.04412168 |
90 | Protrusio acetabuli (HP:0003179) | 2.03185366 |
91 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.02456881 |
92 | Autoimmune thrombocytopenia (HP:0001973) | 1.99358453 |
93 | Ketoacidosis (HP:0001993) | 1.99305054 |
94 | Recurrent skin infections (HP:0001581) | 1.98732882 |
95 | Hyperglycinuria (HP:0003108) | 1.96234771 |
96 | Woolly hair (HP:0002224) | 1.96072183 |
97 | Ventricular tachycardia (HP:0004756) | 1.95481524 |
98 | Skin nodule (HP:0200036) | 1.94391338 |
99 | Asymmetric septal hypertrophy (HP:0001670) | 1.94130286 |
100 | Fragile skin (HP:0001030) | 1.91898011 |
101 | Hypotrichosis (HP:0001006) | 1.89630039 |
102 | Distal lower limb muscle weakness (HP:0009053) | 1.89569396 |
103 | Aortic dissection (HP:0002647) | 1.88985327 |
104 | Abnormality of nucleobase metabolism (HP:0010932) | 1.87341967 |
105 | Ileus (HP:0002595) | 1.87235813 |
106 | Abnormal hemoglobin (HP:0011902) | 1.85118784 |
107 | Pathologic fracture (HP:0002756) | 1.84966756 |
108 | Hemorrhage of the eye (HP:0011885) | 1.83899642 |
109 | Orchitis (HP:0100796) | 1.82890980 |
110 | Ovoid vertebral bodies (HP:0003300) | 1.82552972 |
111 | Keratoconjunctivitis sicca (HP:0001097) | 1.80698688 |
112 | Epistaxis (HP:0000421) | 1.79559868 |
113 | Bone pain (HP:0002653) | 1.78730440 |
114 | Hypoglycemic seizures (HP:0002173) | 1.77878311 |
115 | Nail dystrophy (HP:0008404) | 1.77682398 |
116 | Aortic aneurysm (HP:0004942) | 1.77632206 |
117 | Thrombophlebitis (HP:0004418) | 1.77490665 |
118 | Abnormality of carpal bone ossification (HP:0006257) | 1.77275204 |
119 | Pulmonary infiltrates (HP:0002113) | 1.76744545 |
120 | Mediastinal lymphadenopathy (HP:0100721) | 1.76715413 |
121 | Polycythemia (HP:0001901) | 1.76218615 |
122 | Steatorrhea (HP:0002570) | 1.76169897 |
123 | Neurofibrillary tangles (HP:0002185) | 1.76145836 |
124 | Abnormality of methionine metabolism (HP:0010901) | 1.75918661 |
125 | Periodontitis (HP:0000704) | 1.75892709 |
126 | Urticaria (HP:0001025) | 1.75836424 |
127 | Tetraparesis (HP:0002273) | 1.75762936 |
128 | Gingival bleeding (HP:0000225) | 1.75556452 |
129 | Blue sclerae (HP:0000592) | 1.74577424 |
130 | Pulmonary embolism (HP:0002204) | 1.73130100 |
131 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.73117687 |
132 | Hemoptysis (HP:0002105) | 1.73097629 |
133 | Acanthosis nigricans (HP:0000956) | 1.72629760 |
134 | Abnormality of glycine metabolism (HP:0010895) | 1.72423843 |
135 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.72423843 |
136 | Chronic obstructive pulmonary disease (HP:0006510) | 1.71353481 |
137 | Obstructive lung disease (HP:0006536) | 1.71353481 |
138 | Malnutrition (HP:0004395) | 1.71104021 |
139 | Spontaneous abortion (HP:0005268) | 1.68349520 |
140 | Increased connective tissue (HP:0009025) | 1.68156620 |
141 | Focal segmental glomerulosclerosis (HP:0000097) | 1.66638344 |
142 | Arterial thrombosis (HP:0004420) | 1.66638202 |
143 | Gout (HP:0001997) | 1.65050760 |
144 | Wormian bones (HP:0002645) | 1.65005024 |
145 | Nonimmune hydrops fetalis (HP:0001790) | 1.64922069 |
146 | Subacute progressive viral hepatitis (HP:0006572) | 1.64643394 |
147 | Cheilitis (HP:0100825) | 1.63272328 |
148 | Increased IgE level (HP:0003212) | 1.63121930 |
149 | Abnormal cartilage morphology (HP:0002763) | 1.63029937 |
150 | Pustule (HP:0200039) | 1.61699017 |
151 | Cerebral aneurysm (HP:0004944) | 1.61277291 |
152 | Vacuolated lymphocytes (HP:0001922) | 1.61061655 |
153 | Pancreatitis (HP:0001733) | 1.60540310 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 3.75573688 |
2 | MST1R | 3.26930886 |
3 | FRK | 2.82692404 |
4 | TGFBR2 | 2.76143825 |
5 | FGFR4 | 2.66795385 |
6 | MAP3K14 | 2.65747956 |
7 | EPHA3 | 2.51392961 |
8 | MAP3K3 | 2.34275050 |
9 | EPHB1 | 2.13856019 |
10 | RIPK4 | 2.09770120 |
11 | INSRR | 1.95127978 |
12 | TBK1 | 1.90367991 |
13 | PRPF4B | 1.86316918 |
14 | PTK6 | 1.81270890 |
15 | ZAP70 | 1.74582758 |
16 | FER | 1.71614102 |
17 | TRPM7 | 1.70193648 |
18 | JAK1 | 1.68081361 |
19 | RIPK1 | 1.63808634 |
20 | EPHA2 | 1.62282288 |
21 | NEK9 | 1.60834408 |
22 | LATS1 | 1.56671581 |
23 | SIK1 | 1.54174585 |
24 | BCKDK | 1.49804259 |
25 | MET | 1.48867145 |
26 | PKN2 | 1.46825092 |
27 | KSR2 | 1.46816895 |
28 | TTN | 1.43242296 |
29 | MST4 | 1.39797776 |
30 | MAP3K2 | 1.38036362 |
31 | MAPK15 | 1.35038411 |
32 | TRIB3 | 1.33677708 |
33 | * TYK2 | 1.32292126 |
34 | CDC42BPA | 1.31579703 |
35 | EPHB2 | 1.27388760 |
36 | IKBKE | 1.27090032 |
37 | FGR | 1.22051560 |
38 | FGFR3 | 1.21001659 |
39 | KDR | 1.20021302 |
40 | PIK3CG | 1.19627441 |
41 | IKBKB | 1.17175755 |
42 | TIE1 | 1.15431146 |
43 | PDGFRA | 1.14014000 |
44 | PDPK1 | 1.13662517 |
45 | PTK2 | 1.13591078 |
46 | MYLK | 1.13148278 |
47 | ERBB3 | 1.10804754 |
48 | JAK2 | 1.09037487 |
49 | FLT3 | 1.07591290 |
50 | MAP3K6 | 1.06642803 |
51 | YES1 | 1.05816180 |
52 | IRAK3 | 1.05681649 |
53 | LRRK2 | 1.05428842 |
54 | MAPKAPK3 | 1.02523580 |
55 | MAP2K2 | 0.99212318 |
56 | TGFBR1 | 0.99073893 |
57 | FGFR2 | 0.98446884 |
58 | STK24 | 0.97792890 |
59 | CHUK | 0.95151319 |
60 | BLK | 0.94475213 |
61 | CSK | 0.92860179 |
62 | STK38L | 0.92325287 |
63 | MAP3K12 | 0.89883027 |
64 | JAK3 | 0.88250642 |
65 | ACVR1B | 0.85620898 |
66 | MATK | 0.85021919 |
67 | MAP3K13 | 0.85002360 |
68 | TAOK1 | 0.83689011 |
69 | ICK | 0.83680641 |
70 | ERBB4 | 0.82953018 |
71 | MAP2K1 | 0.82466799 |
72 | LMTK2 | 0.81910144 |
73 | HCK | 0.81741530 |
74 | RET | 0.80042295 |
75 | BMX | 0.79709519 |
76 | PDK1 | 0.78834635 |
77 | STK10 | 0.78815791 |
78 | STK3 | 0.76623621 |
79 | MAP3K11 | 0.76506845 |
80 | DYRK1B | 0.75973843 |
81 | MAP2K3 | 0.74965553 |
82 | SMG1 | 0.74349844 |
83 | FES | 0.73293481 |
84 | MAP3K1 | 0.72367960 |
85 | NUAK1 | 0.71935088 |
86 | TAOK2 | 0.71745343 |
87 | NLK | 0.71425144 |
88 | CDK12 | 0.69604382 |
89 | GRK7 | 0.69478157 |
90 | PRKAA2 | 0.69115208 |
91 | GRK6 | 0.68979012 |
92 | CDK6 | 0.68189053 |
93 | PRKD2 | 0.67370950 |
94 | BMPR1B | 0.67329455 |
95 | LATS2 | 0.66766139 |
96 | RPS6KA4 | 0.66683959 |
97 | ABL2 | 0.66644377 |
98 | TAOK3 | 0.65198988 |
99 | DDR2 | 0.64742788 |
100 | IRAK4 | 0.64052824 |
101 | IRAK2 | 0.63873563 |
102 | MAP4K1 | 0.62835604 |
103 | STK38 | 0.62507588 |
104 | GSK3A | 0.61553284 |
105 | PIK3CA | 0.59711077 |
106 | PAK4 | 0.59280122 |
107 | MAPKAPK2 | 0.57019620 |
108 | MAP3K7 | 0.56230245 |
109 | PDK2 | 0.55462827 |
110 | KIT | 0.54909413 |
111 | PBK | 0.54543257 |
112 | PAK3 | 0.53661369 |
113 | IRAK1 | 0.53414222 |
114 | MARK2 | 0.53230498 |
115 | PIM2 | 0.52821684 |
116 | PRKG2 | 0.51544250 |
117 | MAPK11 | 0.50497159 |
118 | MAPK7 | 0.49966109 |
119 | GRK1 | 0.49660001 |
120 | KSR1 | 0.49644763 |
121 | SIK3 | 0.49584142 |
122 | SGK3 | 0.49375360 |
123 | DMPK | 0.49036431 |
124 | TESK1 | 0.48857226 |
125 | IGF1R | 0.48334254 |
126 | BTK | 0.47897974 |
127 | LYN | 0.46833327 |
128 | BMPR2 | 0.46441042 |
129 | MELK | 0.44535277 |
130 | PDGFRB | 0.41469680 |
131 | EGFR | 0.41293961 |
132 | MOS | 0.40990630 |
133 | LCK | 0.40765760 |
134 | ERBB2 | 0.39987971 |
135 | WNK4 | 0.39560856 |
136 | MAPKAPK5 | 0.38801325 |
137 | ABL1 | 0.38633685 |
138 | CSF1R | 0.37757368 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.18806668 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.98119978 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.73215653 |
4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.70513134 |
5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.55743618 |
6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.33909638 |
7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.32908064 |
8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.26489754 |
9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.24236841 |
10 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.21282823 |
11 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.21249723 |
12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.19440423 |
13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.08326992 |
14 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.01332234 |
15 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.01054343 |
16 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.78588704 |
17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.70539353 |
18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.65739770 |
19 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.65195547 |
20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.57309777 |
21 | Peroxisome_Homo sapiens_hsa04146 | 1.53538554 |
22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.53464429 |
23 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.53214795 |
24 | Retinol metabolism_Homo sapiens_hsa00830 | 1.46314527 |
25 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.41612681 |
26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.41071119 |
27 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.40239531 |
28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.40018595 |
29 | Phagosome_Homo sapiens_hsa04145 | 1.32350327 |
30 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.30480540 |
31 | Bile secretion_Homo sapiens_hsa04976 | 1.28985379 |
32 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.28414465 |
33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.20759492 |
34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.20576632 |
35 | ABC transporters_Homo sapiens_hsa02010 | 1.19272397 |
36 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.16916226 |
37 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.12671992 |
38 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.10720581 |
39 | Allograft rejection_Homo sapiens_hsa05330 | 1.07528876 |
40 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.02349346 |
41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01911171 |
42 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.00113191 |
43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.99137185 |
44 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.96852999 |
45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.95319613 |
46 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.94192244 |
47 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.92140489 |
48 | Salmonella infection_Homo sapiens_hsa05132 | 0.91440974 |
49 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91093248 |
50 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.91009607 |
51 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.90976971 |
52 | Viral myocarditis_Homo sapiens_hsa05416 | 0.90700387 |
53 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.89248861 |
54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.87782116 |
55 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.86473204 |
56 | Malaria_Homo sapiens_hsa05144 | 0.84918419 |
57 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.84783787 |
58 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.84537774 |
59 | Amoebiasis_Homo sapiens_hsa05146 | 0.82530862 |
60 | Leishmaniasis_Homo sapiens_hsa05140 | 0.81652276 |
61 | Pertussis_Homo sapiens_hsa05133 | 0.81419402 |
62 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.81393773 |
63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.81392277 |
64 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.79578669 |
65 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.79053687 |
66 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.78438365 |
67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77128799 |
68 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.77103408 |
69 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.76960059 |
70 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.75332009 |
71 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.75331347 |
72 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.74596772 |
73 | Asthma_Homo sapiens_hsa05310 | 0.73877138 |
74 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.73867825 |
75 | Measles_Homo sapiens_hsa05162 | 0.72893548 |
76 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.72736117 |
77 | Platelet activation_Homo sapiens_hsa04611 | 0.70579474 |
78 | Shigellosis_Homo sapiens_hsa05131 | 0.70318813 |
79 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.70212682 |
80 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.70198708 |
81 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.69962876 |
82 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.68537390 |
83 | Bladder cancer_Homo sapiens_hsa05219 | 0.68131131 |
84 | Mineral absorption_Homo sapiens_hsa04978 | 0.66916636 |
85 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.64937575 |
86 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.63942821 |
87 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.63165879 |
88 | Hepatitis B_Homo sapiens_hsa05161 | 0.62793020 |
89 | Insulin resistance_Homo sapiens_hsa04931 | 0.62666103 |
90 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.61769096 |
91 | Legionellosis_Homo sapiens_hsa05134 | 0.61350982 |
92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60108286 |
93 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.59592627 |
94 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.58856320 |
95 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58814071 |
96 | Apoptosis_Homo sapiens_hsa04210 | 0.58742112 |
97 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.58682748 |
98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58659255 |
99 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.56711266 |
100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56525025 |
101 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.56440190 |
102 | Endocytosis_Homo sapiens_hsa04144 | 0.56311870 |
103 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56248418 |
104 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.55775094 |
105 | Adherens junction_Homo sapiens_hsa04520 | 0.55685206 |
106 | Lysosome_Homo sapiens_hsa04142 | 0.55223379 |
107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54952318 |
108 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.54804479 |
109 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.53791092 |
110 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53144957 |
111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52854271 |
112 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.52549652 |
113 | Carbon metabolism_Homo sapiens_hsa01200 | 0.52136011 |
114 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.51475566 |
115 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.51399522 |
116 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.49988016 |
117 | Focal adhesion_Homo sapiens_hsa04510 | 0.49334675 |
118 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.48026030 |
119 | Hepatitis C_Homo sapiens_hsa05160 | 0.47808682 |
120 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.47719512 |
121 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.47674280 |
122 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.47133470 |
123 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46400830 |
124 | Prion diseases_Homo sapiens_hsa05020 | 0.46137208 |
125 | Lysine degradation_Homo sapiens_hsa00310 | 0.41114482 |
126 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.39536960 |
127 | Other glycan degradation_Homo sapiens_hsa00511 | 0.39075931 |
128 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38698378 |
129 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.38589821 |
130 | Influenza A_Homo sapiens_hsa05164 | 0.38292630 |
131 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.37981884 |
132 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.37486185 |
133 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36789016 |
134 | Tuberculosis_Homo sapiens_hsa05152 | 0.35849833 |
135 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.35723724 |
136 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.34325028 |
137 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.33957094 |
138 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31327002 |
139 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.31090052 |
140 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.30117936 |